The classic diagnostic approach to PCa, based on systematic biopsies after elevated serum prostate-specific antigen (PSA) and/or abnormal digital rectal examination (DRE) [2], has been disapproved due to high rates of unnecessary biopsies and an over detection of insignificant PCa (iPCa) [3]. The gene discussed is KLK3; the disease is posterior cortical atrophy.